Padayatchi N, Mahomed S, Loveday M, Naidoo K.
Expert Opinion On Pharmacotherapy 2016 August. DOI: 10.1080/14656566.2016.1225724
Sobieszczyk ME, Werner L, Mlisana K, Naicker N, Feinstein A, Gray CM, Masson L, Passmore J-AS, Williamson C, Abdool Karim Q, Abdool Karim SS, Garrett NG.
JAIDS 2016 July. DOI: 10.1097/QAI.0000000000001123
Padayatchi N, Naidu N, Yende-Zuma N, O’Donnell MR, Naidoo K, Augustine S, Zumla A, Loveday M.
JAIDS 2016 September; 73(1):e1-7. doi: 10.1097/QAI.0000000000001110.
Koofhethile CK, Ndhlovu ZM, Thobakgale-Tshabalala C, Prado JG, Ismail N, Mncube Z, Mkhize I, Van der Stok M, Yende-Zuma N, Walker BD, Goulder PJ, Ndung'u T.
Journal of Virology 2016 July; 90(15):6818-31. doi: 10.1128/JVI.00276-16.
Archary D, Seaton KE, Passmore JS, Werner L, Deal A, Dunphy LI, Arnold KB, Yates NL, Lauffenburger DA, Bergin P, LiebenbergLI, Samsunder N, Mureithi MW, Altfeld M, Garrett N, Abdool Karim Q, Abdool Karim SS, Morris L, and Tomaras GD.
Mucosal Immunology 2016 May; 9(3): 821–833. doi:10.1038/mi.2015.145.
Daftary A, Hirsch-Moverman Y, Kassie GM, Melaku Z, Gadisa T, Saito S, Howard AA.
AIDS and Behavior 2016 May 24. Doi:10.1007/s10461-016-1432-8
CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.